Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-15 Sale |
2021-01-20 6:46 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $71.45 | $3,572,556 | 960,177 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 6:50 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
70,000 | $74.95 | $5,246,408 | 675,248 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 6:49 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
88,334 | $74.96 | $6,621,782 | 2,562,978 (Indirect Direct) |
View |
| 2020-12-21 Sale |
2020-12-23 9:52 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
30,000 | $90.05 | $2,701,582 | 57,464 (Indirect Direct) |
View |
| 2020-12-11 Sale |
2020-12-15 4:47 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) |
View |
| 2020-11-12 Sale |
2020-11-13 5:13 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
30,000 | $70.05 | $2,101,590 | 274,998 (Indirect Direct) |
View |
| 2020-11-10 Sale |
2020-11-12 4:21 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
10,000 | $60.03 | $600,310 | 304,998 (Indirect Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 5:53 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
10,000 | $50.18 | $501,830 | 314,998 (Indirect Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 6:45 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $40.74 | $2,155,603 | 342,132 (Indirect Direct) |
View |
| 2020-09-10 Sale |
2020-09-14 9:38 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
3,689 | $31 | $114,359 | 190,141 (Indirect) |
View |
| 2020-08-12 Sale |
2020-08-14 4:50 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
1,443,247 | $31.65 | $45,678,768 | 12,649,669 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-08 Option Award |
2021-01-12 6:44 pm |
N/A 2031-01-07 |
Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director |
10,046 | $0 | 10,046 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:55 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:54 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:50 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
120,000 | $0 | 675,248 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:49 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
240,000 | $0 | 2,562,978 (Direct) |
View |
| 2020-12-21 Other |
2020-12-23 6:44 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
383,411 | $0 | 12,585,045 (Indirect) |
View |
| 2020-08-20 Exercise(A) |
2020-11-30 6:11 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
5,643 | $0 | 625,248 (Indirect) |
View |
| 2020-08-21 Tax Withholding(A) |
2020-11-30 6:11 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
1,954 | $32.88 | 625,248 (Indirect) |
View |
| 2020-10-08 Exercise |
2020-10-13 6:45 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $5.28 | 342,132 (Indirect) |
View |
| 2020-10-08 Exercise |
2020-10-13 6:45 pm |
N/A 2026-07-01 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
52,906 | $0 | 342,132 (Direct) |
View |
Ownership |
2020-09-28 4:30 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BIOGEN INC. Biogen MA Inc. 10% Owner |
0 | $0 | 13,310,243 (Indirect) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:38 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
5,643 | $0 | 158,320 (Direct) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:38 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,954 | $32.88 | 158,320 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
5,643 | $0 | 622,468 (Direct) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
1,954 | $32.88 | 622,468 (Indirect) |
View |
| 2020-08-21 Tax Withholding |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,954 | $32.87 | 1,010,177 (Indirect) |
View |
| 2020-08-20 Exercise |
2020-08-24 8:37 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
5,643 | $0 | 1,010,177 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:20 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:19 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:17 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-08-18 Option Award |
2020-08-20 6:14 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
20,000 | $0 | 20,000 (Direct) |
View |